TW201613907A - Antibacterial basic biaromatic derivatives with aminoalkoxy substitution - Google Patents

Antibacterial basic biaromatic derivatives with aminoalkoxy substitution

Info

Publication number
TW201613907A
TW201613907A TW104133759A TW104133759A TW201613907A TW 201613907 A TW201613907 A TW 201613907A TW 104133759 A TW104133759 A TW 104133759A TW 104133759 A TW104133759 A TW 104133759A TW 201613907 A TW201613907 A TW 201613907A
Authority
TW
Taiwan
Prior art keywords
compounds
aminoalkoxy
substitution
antibacterial
gram
Prior art date
Application number
TW104133759A
Other languages
English (en)
Inventor
Sylvaine Cren
Astrid Friedli
Georg Rueedi
Cornelia Zumbrunn
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of TW201613907A publication Critical patent/TW201613907A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53831,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW104133759A 2014-10-15 2015-10-14 Antibacterial basic biaromatic derivatives with aminoalkoxy substitution TW201613907A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14189026 2014-10-15

Publications (1)

Publication Number Publication Date
TW201613907A true TW201613907A (en) 2016-04-16

Family

ID=51743312

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104133759A TW201613907A (en) 2014-10-15 2015-10-14 Antibacterial basic biaromatic derivatives with aminoalkoxy substitution

Country Status (14)

Country Link
US (1) US9850256B2 (zh)
EP (1) EP3207042B1 (zh)
JP (1) JP2017531008A (zh)
KR (1) KR20170066644A (zh)
CN (1) CN106795171A (zh)
AR (1) AR102256A1 (zh)
AU (1) AU2015332747A1 (zh)
BR (1) BR112017007438A2 (zh)
CA (1) CA2963699A1 (zh)
ES (1) ES2702214T3 (zh)
MX (1) MX2017004891A (zh)
RU (1) RU2017116617A (zh)
TW (1) TW201613907A (zh)
WO (1) WO2016059097A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA030067B1 (ru) 2013-07-22 2018-06-29 Идорсиа Фармасьютиклз Лтд Производные 1-(пиперазин-1-ил)-2-([1,2,4]триазол-1-ил)этанона
SI3245203T1 (sl) * 2015-01-15 2019-03-29 Idorsia Pharmaceuticals Ltd Derivati hiroksialkil-piperazina kot modulatorji receptorja CXCR3
AR103399A1 (es) 2015-01-15 2017-05-10 Actelion Pharmaceuticals Ltd Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
AR108108A1 (es) * 2016-04-14 2018-07-18 Idorsia Pharmaceuticals Ltd Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi
GB2550437B (en) * 2016-05-20 2021-06-23 Bugworks Res Inc Heterocyclic compounds useful as anti-bacterial agents and method for production
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
WO2018202524A1 (de) 2017-05-04 2018-11-08 Bayer Cropscience Aktiengesellschaft 2-{[2-(phenyloxymethyl)pyridin-5-yl]oxy}-ethanamin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel z.b. für den pflanzenschutz
JP2019019124A (ja) * 2017-07-19 2019-02-07 日本化薬株式会社 ピラジン化合物
CN117980303A (zh) * 2021-09-20 2024-05-03 豪夫迈·罗氏有限公司 新化合物以及它们在治疗细菌感染中的用途
CN117999261A (zh) * 2021-09-20 2024-05-07 豪夫迈·罗氏有限公司 新化合物以及它们在治疗细菌感染中的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802239A1 (de) 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CN105541769A (zh) 2007-06-29 2016-05-04 奥克塞拉有限公司 用于治疗眼科疾病和紊乱的炔基苯基衍生化合物
PL2245028T3 (pl) 2007-12-18 2012-07-31 Actelion Pharmaceuticals Ltd Pochodne 5-aminocyklilometyloksazolidyn-2-onu
JP5349500B2 (ja) * 2008-02-20 2013-11-20 アクテリオン ファーマシューティカルズ リミテッド アザトリシクリック抗菌性化合物
CA2713187C (en) 2008-02-22 2016-06-07 Actelion Pharmaceuticals Ltd Oxazolidinone derivatives
MX2011000968A (es) * 2008-08-04 2011-03-02 Actelion Pharmaceuticals Ltd Derivados de alquilaminometiloxazolidinona triciclicos.
AR073774A1 (es) 2008-10-07 2010-12-01 Actelion Pharmaceuticals Ltd Compuestos antibioticos oxazolidinona triciclicos
ES2628091T3 (es) 2008-10-10 2017-08-01 Idorsia Pharmaceuticals Ltd Antibióticos de oxazolidinilo
EP2346862B1 (en) 2008-10-10 2012-09-12 Actelion Pharmaceuticals Ltd. 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
US8575364B2 (en) 2008-10-30 2013-11-05 Janssen Pharmaceutica Nv Modulators of serotonin receptor
KR20140054057A (ko) * 2011-08-11 2014-05-08 액테리온 파마슈티칼 리미티드 퀴나졸린-2,4-디온 유도체
CA2854264A1 (en) 2011-11-08 2013-05-16 Actelion Pharmaceuticals Ltd 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
AU2014255326B2 (en) * 2013-04-16 2018-09-13 Idorsia Pharmaceuticals Ltd Antibacterial biaromatic derivatives

Also Published As

Publication number Publication date
EP3207042A1 (en) 2017-08-23
EP3207042B1 (en) 2018-10-03
MX2017004891A (es) 2017-12-07
AU2015332747A1 (en) 2017-06-01
BR112017007438A2 (pt) 2018-01-16
ES2702214T3 (es) 2019-02-27
US20170305927A1 (en) 2017-10-26
CN106795171A (zh) 2017-05-31
JP2017531008A (ja) 2017-10-19
US9850256B2 (en) 2017-12-26
KR20170066644A (ko) 2017-06-14
RU2017116617A (ru) 2018-11-15
WO2016059097A1 (en) 2016-04-21
AR102256A1 (es) 2017-02-15
CA2963699A1 (en) 2016-04-21

Similar Documents

Publication Publication Date Title
TW201613907A (en) Antibacterial basic biaromatic derivatives with aminoalkoxy substitution
PH12016501577A1 (en) Monobactam organic compounds for the treatment of bacterial infections
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
PH12016502436A1 (en) Anti-infective compounds
PH12019500360A1 (en) Antibiotic compounds
NZ593111A (en) Antibacterial compounds
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
MX2016009248A (es) Compuestos que contienen nitrogeno y su uso como agentes antibacterianos.
WO2018208987A3 (en) Antibacterial compounds
CL2016001524A1 (es) Derivados antibacterianos de 1h-indazol y 1h-indol.
MX2011008043A (es) Derivados de actagardina.
MX2017009094A (es) Derivado de polimixina y usos del mismo.
ZA202002093B (en) Antibacterial compounds
CL2017001276A1 (es) Derivados de benzotiazol antibacterianos
WO2015024011A3 (en) Antibacterial compounds
PH12016501532A1 (en) Antibacterial combinations comprising polymyxin
PH12019502509A1 (en) Compounds and methods for treating bacterial infections
MX2015015251A (es) Derivados de la quinolona.
MX2018012558A (es) Derivados biaromaticos antibacterianos con sustitucion de oxetan-3-iloxi.
PH12015501428A1 (en) Antibacterial compounds
JO3477B1 (ar) مركبات أحادي باكتام عضوية لعلاج العدوى البكتيرية
MX2019009558A (es) Compuestos antibioticos de ariloxazolidinona.
CR20160412A (es) Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas
UA108238C2 (xx) Антибактеріальна композиція